USPTO serial 79070625
ROSTAQUO
Reviewed by CopyMark Law Group
Reg. 3811086Status 404
- Filing date
- Status date
- Registration date
- Jun 29, 2010
- Examiner
- THOMAS, JANICE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ROSTAQUO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes and metabolic diseases, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in hematology, in oncology, in transplantation, in ophthalmology, for use in the gastroenterological areas and the prevention and treatment of ocular disorders or diseases, anti-infectives, pharmaceutical preparations treating bacterial-bases disease, antivirals, anti-biotics, antifungals, vaccines, diagnostic preparations for medical use | SECTION 71 - CANCELLED | — |
| 039 | Transportation of pharmaceutical preparations by road, rail, air and sea transportation; packaging and storage of goods, namely, pharmaceutical preparations | SECTION 71 - CANCELLED | — |
| 042 | Scientific, medical and industrial research services for new products in the field of science, health, medicine and nutrition; research and development services for new products in the fields of science, health, medicine and nutrition; design services for chemical products, proprietary medicines and pharmaceutical procedures in production of pharmacologically active substance and preparations, nutraceuticals and nutritional preparations; scientific and medical testing and diagnoses of chemical products, pharmaceutical products, nutraceuticals and nutritional preparations; chemical, biological and bacteriological analysis; design and development of computers and software | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ROSTAQUO S.p.A.
- Other trademarks owned by ROSTAQUO S.p.A.
- Other trademarks owned by ROSTAQUO S.p.A.
- Other trademarks in Class 005
- Other trademarks in Class 039
- Other trademarks in Class 042
- Similar marks named ROSTAQUO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 25, 2019 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Oct 25, 2019 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Oct 27, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Oct 5, 2017 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Oct 5, 2017 | INPC | INVALIDATION PROCESSED | — |
| Oct 3, 2017 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 3, 2017 | C71T | CANCELLED SECTION 71 | — |
| Feb 12, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 21, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 21, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 30, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 29, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 13, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 13, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 9, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 9, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 9, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 9, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 8, 2010 | ALIE | ASSIGNED TO LIE | — |
| Feb 26, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 26, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 29, 2009 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 26, 2009 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 26, 2009 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 25, 2009 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 24, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 22, 2009 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 18, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 18, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 17, 2009 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| Aug 6, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |